MX2011011206A - Composiciones topicas estables para derivados de 1,2,4-tiadiazol. - Google Patents
Composiciones topicas estables para derivados de 1,2,4-tiadiazol.Info
- Publication number
- MX2011011206A MX2011011206A MX2011011206A MX2011011206A MX2011011206A MX 2011011206 A MX2011011206 A MX 2011011206A MX 2011011206 A MX2011011206 A MX 2011011206A MX 2011011206 A MX2011011206 A MX 2011011206A MX 2011011206 A MX2011011206 A MX 2011011206A
- Authority
- MX
- Mexico
- Prior art keywords
- stable
- stable topical
- topical composition
- composition
- thiadiazole derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente solicitud proporciona una composición tópica estable que comprende un compuesto de derivados de 1,2,4-tiadiazola y los derivados de tiourea relacionados; la composición tópica estable puede estar presente en varias formas, incluyendo gel acuoso, crema y emulsión; la composición tópica estable puede almacenarse en condiciones refrigeradas o a temperatura ambiente por un tiempo razonable; la presente solicitud también proporciona un método de tratamiento de trastornos dermatológicos mediados por un receptor de melanocortina que utiliza la composición tópica estable; la composición estable puede suministrarse utilizando un dispositivo de una cámara o de doble cámara; también se proporciona un método de preparación y suministro de la composición estable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17252609P | 2009-04-24 | 2009-04-24 | |
PCT/US2010/032186 WO2010124175A1 (en) | 2009-04-24 | 2010-04-23 | Stable topical compositions for 1,2,4-thiadiazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011011206A true MX2011011206A (es) | 2012-02-28 |
Family
ID=42237364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011011206A MX2011011206A (es) | 2009-04-24 | 2010-04-23 | Composiciones topicas estables para derivados de 1,2,4-tiadiazol. |
Country Status (15)
Country | Link |
---|---|
US (3) | US20100273838A1 (es) |
EP (1) | EP2421521A1 (es) |
JP (1) | JP2012524814A (es) |
KR (1) | KR20120044287A (es) |
CN (1) | CN102458384A (es) |
AU (1) | AU2010238710A1 (es) |
BR (1) | BRPI1013853A2 (es) |
CA (1) | CA2759730A1 (es) |
CL (1) | CL2011002648A1 (es) |
MX (1) | MX2011011206A (es) |
NZ (1) | NZ596138A (es) |
RU (1) | RU2011147592A (es) |
SG (2) | SG10201401006QA (es) |
WO (1) | WO2010124175A1 (es) |
ZA (1) | ZA201108618B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7319107B2 (en) * | 2001-11-08 | 2008-01-15 | Johnson & Johnson Consumer Companies, Inc. | 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
US8247453B2 (en) | 2008-02-21 | 2012-08-21 | Janssen Pharmaceutica, Nv | Methods for the treatment of dermatological disorders |
CN102834096A (zh) * | 2010-01-14 | 2012-12-19 | 卢福研究公司 | 用于疼痛控制的固态成型局部麻醉制剂 |
US9132291B2 (en) | 2010-10-05 | 2015-09-15 | Dfb Technology, Ltd. | Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa |
FR2967054B1 (fr) * | 2010-11-05 | 2013-01-25 | Lea Lab | Systeme conservateur |
US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US20140023979A1 (en) * | 2012-07-18 | 2014-01-23 | Maha Mohamed Fouad Mounir | Regeneration of ameloblast cells and dental enamel in vivo |
US20150290217A1 (en) * | 2012-11-21 | 2015-10-15 | Trimel Biopharma Srl | Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
JP6480847B2 (ja) * | 2014-10-15 | 2019-03-13 | 第一三共ヘルスケア株式会社 | ロキソプロフェン含有外用剤組成物 |
TW201630606A (zh) * | 2015-01-21 | 2016-09-01 | 諾華公司 | 包含局部藥物之蓋崙(galenic)調配物 |
EA035300B1 (ru) * | 2015-12-15 | 2020-05-26 | Терапьютикс Инк. | Вспениваемая композиция галобетазола (варианты) и способ лечения |
KR101966673B1 (ko) * | 2016-11-21 | 2019-04-08 | 에이디인터내셔날㈜ | 항균탈취 조성물 |
CN109400724B (zh) * | 2018-11-05 | 2021-04-02 | 中国科学院烟台海岸带研究所 | 一种含噻二唑脲类乙酰化淀粉及其制备方法和应用 |
KR20200053746A (ko) | 2018-11-09 | 2020-05-19 | (주)아모레퍼시픽 | 졸-겔 조성물 |
CN114292689B (zh) * | 2021-12-07 | 2023-03-31 | 广州崃克保新材料科技有限公司 | 一种脱模剂组合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020103194A1 (en) * | 1997-04-30 | 2002-08-01 | Anabella Villalobos | Novel muscarinic receptor agonists |
ATE208767T1 (de) * | 1996-04-30 | 2001-11-15 | Pfizer | Muscarinische rezeptor-agonisten |
CN1111523C (zh) * | 1998-04-29 | 2003-06-18 | 阿克西瓦有限公司 | 催化制备取代的联吡啶衍生物的方法 |
US6294534B1 (en) * | 1998-06-11 | 2001-09-25 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
US7049331B2 (en) * | 2001-11-08 | 2006-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
US7319107B2 (en) * | 2001-11-08 | 2008-01-15 | Johnson & Johnson Consumer Companies, Inc. | 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
US7435429B2 (en) * | 2002-02-07 | 2008-10-14 | Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
US8247453B2 (en) * | 2008-02-21 | 2012-08-21 | Janssen Pharmaceutica, Nv | Methods for the treatment of dermatological disorders |
-
2010
- 2010-04-23 SG SG10201401006QA patent/SG10201401006QA/en unknown
- 2010-04-23 BR BRPI1013853A patent/BRPI1013853A2/pt not_active IP Right Cessation
- 2010-04-23 SG SG2011077674A patent/SG175773A1/en unknown
- 2010-04-23 EP EP10715466A patent/EP2421521A1/en not_active Withdrawn
- 2010-04-23 NZ NZ596138A patent/NZ596138A/xx not_active IP Right Cessation
- 2010-04-23 RU RU2011147592/15A patent/RU2011147592A/ru not_active Application Discontinuation
- 2010-04-23 CA CA2759730A patent/CA2759730A1/en not_active Abandoned
- 2010-04-23 CN CN2010800290447A patent/CN102458384A/zh active Pending
- 2010-04-23 KR KR1020117027782A patent/KR20120044287A/ko not_active Application Discontinuation
- 2010-04-23 US US12/765,981 patent/US20100273838A1/en not_active Abandoned
- 2010-04-23 AU AU2010238710A patent/AU2010238710A1/en not_active Abandoned
- 2010-04-23 JP JP2012507412A patent/JP2012524814A/ja active Pending
- 2010-04-23 MX MX2011011206A patent/MX2011011206A/es not_active Application Discontinuation
- 2010-04-23 WO PCT/US2010/032186 patent/WO2010124175A1/en active Application Filing
-
2011
- 2011-10-24 CL CL2011002648A patent/CL2011002648A1/es unknown
- 2011-11-23 ZA ZA2011/08618A patent/ZA201108618B/en unknown
-
2013
- 2013-03-15 US US13/835,418 patent/US20130210868A1/en not_active Abandoned
- 2013-03-15 US US13/836,370 patent/US20130203823A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2010238710A1 (en) | 2011-11-17 |
US20130203823A1 (en) | 2013-08-08 |
CA2759730A1 (en) | 2010-10-28 |
SG10201401006QA (en) | 2014-10-30 |
BRPI1013853A2 (pt) | 2019-09-24 |
US20100273838A1 (en) | 2010-10-28 |
NZ596138A (en) | 2013-11-29 |
CN102458384A (zh) | 2012-05-16 |
EP2421521A1 (en) | 2012-02-29 |
SG175773A1 (en) | 2011-12-29 |
JP2012524814A (ja) | 2012-10-18 |
ZA201108618B (en) | 2013-05-29 |
CL2011002648A1 (es) | 2012-07-20 |
WO2010124175A1 (en) | 2010-10-28 |
US20130210868A1 (en) | 2013-08-15 |
KR20120044287A (ko) | 2012-05-07 |
RU2011147592A (ru) | 2013-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011011206A (es) | Composiciones topicas estables para derivados de 1,2,4-tiadiazol. | |
MX337454B (es) | Composicion acuosa que contiene bromhexina. | |
WO2007137066A3 (en) | HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME | |
MX2011008391A (es) | Combinacion de avermectinas o milbemicinas con receptores adrenergicos para el tratamiento o prevencion de las afeccione dermatologicas. | |
EP1920774A4 (en) | COMPOSITION CONTAINING FUCOIDAN OR FUCOIDAN HYDROLYSAT AND AN IMMUNOSTIMULATING SUBSTANCE | |
WO2009109927A3 (en) | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | |
MX2007012279A (es) | Metodo para regular tejido queratinoso de mamifero. | |
SG151329A1 (en) | Amido compounds and their use as pharmaceuticals | |
WO2006002361A3 (en) | 2-methylpropanamides and their use as pharmaceuticals | |
WO2007038138A3 (en) | Amido compounds and their use as pharmaceuticals | |
AR068369A1 (es) | Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina" | |
RS20080440A (en) | Novel compositions for hair disorders and process of preparation thereof | |
WO2012127501A3 (en) | Composition for improving endometrial thickness during ovarian stimulation | |
WO2015095354A3 (en) | Compositions and methods for treating fatty tissue buildup | |
EP2275104A3 (en) | Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid | |
WO2018143552A3 (ko) | 탈모방지 또는 발모촉진용 주사용 조성물 | |
MX2010004373A (es) | Materiales miscibles en agua no acuosos como vehiculos para suministro de farmacos. | |
WO2008070859A3 (en) | Treatment of skin conditions by dickkopf1 (dkk1) | |
MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
WO2011049327A3 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
UA105920C2 (uk) | ПОХІДНІ СПОЛУК СТЕРОЇДАЛ[3,2-с]ПІРАЗОЛУ З ГЛЮКОКОРТИКОЇДНОЮ АКТИВНІСТЮ | |
MX2015017879A (es) | Derivados de estratrientiazol 17-nitrogeno substitutidos terapeuticamente activos como inhibidores de 17.beta-hidroxiestero ide deshidrogenasa. | |
WO2008112596A3 (en) | Implantable device with bioabsorbable layer, kit and method for use therewith, and apparatus for preparing same | |
MX2009003060A (es) | Emulsion. | |
WO2008120542A1 (ja) | ミチヤナギを有効成分とする固形製剤形態を有する食品組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |